Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential (Q43253857)
Jump to navigation
Jump to search
scientific article published on 27 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential |
scientific article published on 27 October 2009 |
Statements
1 reference
Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential (English)
1 reference
Thomas Unger
1 reference
27 October 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference